Navigation Links
Osteocalcin IRMA Test

ProductsOsteocalcin IRMA Test
Company Diagnostic Systems Laboratories, Inc.
Item Osteocalcin IRMA Test
Features Inquire
Description Osteocalcin, also known as bone Gla protein, is a vitamin K-dependent, calcium binding protein which is a major component of the noncollagenous bone matrix [1,2,3]. Osteocalcin is synthesized by osteoblasts in bone, with a small amount produced by odontoblasts in dentin, and hypertrophic chondrocytes [1]. During bone formation, newly synthesized osteocalcin is incorporated into the extracellular bone matrix and a small fraction is released into circulation. Because serum osteocalcin originates exclusively from bone, serum osteocalcin levels reflect bone formation activity [1]. Osteocalcin is also released into serum from the bone matrix during osteoblastic bone resorption. However, this circulates as non-immunoreactive fragments that are rapidly metabolized in the kidney and, to a lesser extent, in the liver [5]. Serum osteocalcin is elevated in disease states characterized by increased bone turnover such as renal osteodystrophy, osteoporosis, hyperparathyroidism and Pagets disease, and low in conditions associated with low bone turnover such as hypoparathyroidism and growth hormone deficiency [1]. Serum osteocalcin measurements are also useful in osteoporosis research, and have shown good correlation with bone histomorphometric measurements [6] and for studying the effects of treatments that modulate bone formation activity [7]. Serum osteocalcin measurements have also been useful in the research of toxic effects on bone [6,8].

  1. Gundberg CM. J Clin Ligand Assay 21:128-138, 1998.
  2. Price PA, et al. Proc Natl Acad Sci USA 73:3374-3375, 1976.
  3. Gallop PM, et al. New Engl J Med 302:1460, 1980.
  4. Price PA, et al. J Biol Chem 256:12760, 1981.
  5. Farrugia W & Melik RA. Calcif Tissue Int 39:234, 1986.
  6. Bikle DD. Am J Med 103:427-436, 1997.
  7. Castracane VD et al. J Bone Min Res 12:S500, 1997.
  8. Kido T et al. Arch Environ Hlth 46:43-49, 1991.
Info Diagnostic Systems Laboratories, Inc.
Customer Service: (800) 231-7970
Web site: http://www.dslabs.com

Related medicine products :

1. Osteocalcin ELISA Test
2. Osteocalcin by Electrochemiluminescent Immunoassay
...y that a second mirror adds, then you may want to ...same 1.5x magnification as the G-1 but offers two ... Available in standard (flange) or new glass NF (n...anged" model for laser use. Provides broader vie...
Direct Image AFX SSV®
Direct Image High-Mag SSV®
Direct Image Mid Field
Medicine Products:
(Date:11/25/2009)...wswire/-SentinelleMedicalInc.,aleadingmanufacturer...CalgaryScientificInc.,aleadingproviderofsoftwareen...s(TM)Breast4DAdvancedVisualizationsoftware. ,, ...ntWebclientbasedmedicalimagingofferinginthemarket....o-footprintaccess-requiringnosoftwaredownload,andr...
(Date:11/25/2009)...swire-USNewswire/--AnarticlebyJanetWoodcock,M.D.,d...h,titled"ADifficultBalance-PainManagement,DrugSafe...EnglandJournalofMedicine. ,, (Logo: http://www....Inthearticle,WoodcockdiscussesFDAeffortstostrikeab...itandmanagingtherisksposedbyvariousanalgesics.Asex...
(Date:11/25/2009)...usiness,andPressJoinEfforttoEducate ,, MEMPHIS...eNationalBipolarFoundationandtheMedicAlertFoundati...e"program,whichisnowbeingwidelyacceptedasapreventi...ionalBipolarFoundationreceivedaproclamationofendor...norofLouisianaMitchLandrieu.TheNationalBipolarFoun...
(Date:11/25/2009)...out of a collaboration between UCLA engineers and ...rly 10 million Americans who suffer from periphera...g of the arteries, peripheral arterial disease, or...rowed arteries reduce blood flow to the limbs. The...isease, heart attack and stroke, and its progressi...
(Date:11/25/2009)...matoid arthritis, could help newly diagnosed diabe... (HealthDay News) -- A drug commonly used to treat...ow also shows some promise in helping patients new...rituximab (Rituxan), helped patients keep producin...se had destroyed some of their pancreatic beta cel...
Breaking Medicine News(10 mins):Health News:Sentinelle Medical Inc. Introduces Aegis(TM) Web Powered By Calgary Scientific's PureWeb Technology 2Health News:Sentinelle Medical Inc. Introduces Aegis(TM) Web Powered By Calgary Scientific's PureWeb Technology 3Health News:First Time-Door is Open for Family Discussion of Bipolar Disorder 2Health News:First Time-Door is Open for Family Discussion of Bipolar Disorder 3Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 2Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 3Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 4Health News:Type 1 Diabetes May Have a New Foe 2Health News:Type 1 Diabetes May Have a New Foe 3
...ormation is Meaningful,and in Appropriate Context,...logy Association (AdvaMed) today expressed support...ionships with physicians by,putting forth key chan...ed innovation in medical technology relies on dire...
...inating against a variety of infectious diseases ...ther than needles has proved able to produce a st...wo new studies. , The results build on previous s...ines developed at the Michigan Nanotechnology Inst...
...in Florida and Texas, JACKSONVILLE, Fla. and BETH...TM) today announced an agreement to equip physicia...ing service under,Availity,s private label, CarePr...g of Blue Cross and Blue Shield of,Florida, Humana...
...6-month study , , TUESDAY, Feb. 26 (Healt...ins the antiretroviral drug tenofovir is safe for ...a six-month study of 200 women in India and the Un...le to adhere to a regimen of either daily or sex-d...
...nd Fund Health Needs, WASHINGTON, Feb. 26 A coal...a newspaper and radio advertising,campaign in supp...ky,s,cigarette tax by 70 cents per pack, reduce sm... Kentucky lawmakers to support House Bill,443, spo...
...s, Inc. (Nasdaq: ADLS ), a biopharmaceutical comp...ercialization of novel drugs in the,therapeutic ar... today,announced that it will present at Susquehan...cgi-bin/prnh/20080218/ALSLOGO ), Advanced Life Sc...
Other Medicine News:Health News:AdvaMed Supports Key Changes to Disclosure Legislation 2Health News:AdvaMed Supports Key Changes to Disclosure Legislation 3Health News:Nanoemulsion vaccines show increasing promise 2Health News:Nanoemulsion vaccines show increasing promise 3Health News:Nanoemulsion vaccines show increasing promise 4Health News:Availity Engages Prematics to Deploy Electronic Prescribing 2Health News:Availity Engages Prematics to Deploy Electronic Prescribing 3Health News:HIV Drug in Microbicide Gel Safe for Daily Use 2Health News:Health Groups Launch Ad Campaign Supporting 70-Cent Increase in Kentucky Cigarette Tax 2Health News:Advanced Life Sciences to Present at Susquehanna's Second Annual SIGnificant Investment Options in Healthcare Conference 2
(Date:11/25/2009)...-NuVasive,Inc.(Nasdaq: NUVA ),amedicaldevicecompan...surgicaltreatmentsforthespine,announcedtodaythatit...5:30p.m.ET/2:30p.m.PT.Theconferencecallwillfocuson...sproductsandwillincludecommentsfrommanagementfollo...ersare1-877-407-4018fordomesticcallersand1-201-689...
(Date:11/25/2009)...er.comannouncesthatanewmarketresearchreportisavail...USMarketTrends&Analysis http://www.reportlink...et-Trends--Analysis.html ,, TheUSintranasaldru...capplicationsfromthedeliveryofconventionallocalthe...gs.Thefutureofthetechnologyhingesontotheeffectivee...
(Date:11/25/2009)...-- ChemoCentryx,Inc.,announcedtodaythatPhaseII/II...iveRandomizedOralTherapyEvaluationinCrohn,sdisease...erate-to-severeCrohn,sdiseasedemonstratedclinicale...Thestudydemonstratedevidenceofclinicalefficacyinth...reaseintheCrohn,sDiseaseActivityIndex(CDAI)inpatie...
Breaking Medicine Technology:NuVasive Announces Conference Call and Webcast Regarding Reimbursement 2NuVasive Announces Conference Call and Webcast Regarding Reimbursement 3Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 2Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 3Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 4Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 5ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 2ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 3ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 4ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 5Access Pharmaceuticals Provides Update on ProLindac 28TM 29 Phase 2 Ovarian Cancer Trial and Clinical Development Plan 47461 1Access Pharmaceuticals Provides Update on ProLindac 28TM 29 Phase 2 Ovarian Cancer Trial and Clinical Development Plan 47461 2Access Pharmaceuticals Provides Update on ProLindac 28TM 29 Phase 2 Ovarian Cancer Trial and Clinical Development Plan 47461 3Access Pharmaceuticals Provides Update on ProLindac 28TM 29 Phase 2 Ovarian Cancer Trial and Clinical Development Plan 47461 4BayCare Named CIO 100 Award Winner by CIO Magazine 47458 1BayCare Named CIO 100 Award Winner by CIO Magazine 47458 2BayCare Named CIO 100 Award Winner by CIO Magazine 47458 3National Museum of Dentistry Opens New Smile Experience Exhibition Recognizes Dr Irwin Smigel as Father of Aesthetic Dentistry 47455 1National Museum of Dentistry Opens New Smile Experience Exhibition Recognizes Dr Irwin Smigel as Father of Aesthetic Dentistry 47455 2National Museum of Dentistry Opens New Smile Experience Exhibition Recognizes Dr Irwin Smigel as Father of Aesthetic Dentistry 47455 3